NCT02652234View on ClinicalTrials.gov

Study of Endostar Subcutaneous Injection in NSCLC

PHASE1UnknownINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

June 30, 2016

Study Completion Date

September 30, 2016

Conditions
NSCLC
Interventions
DRUG

Endostar

Endostar, ih, QD，day 1 of cycle 1; Endostar, ih, QD，day 2-15 of cycle 3;

DRUG

Chemotherapy

Trial Locations (1)

210000

RECRUITING

Jiangsu Province Cancer Hospital, Nanjing

Sponsors
All Listed Sponsors
lead

Jiangsu Simcere Pharmaceutical Co., Ltd.

INDUSTRY